Don Ilodigwe Selected Research

clazosentan

7/2013	Impact of global cerebral atrophy on clinical outcome after subarachnoid hemorrhage.
1/2013	Sliding dichotomy compared with fixed dichotomization of ordinal outcome scales in subarachnoid hemorrhage trials.
1/2013	Global cerebral atrophy after subarachnoid hemorrhage: a possible marker of acute brain injury and assessment of its impact on outcome.
1/2012	Method of aneurysm treatment does not affect clot clearance after aneurysmal subarachnoid hemorrhage.
4/2011	Cerebral infarction after subarachnoid hemorrhage contributes to poor outcome by vasospasm-dependent and -independent effects.
10/2010	Patient age and vasospasm after subarachnoid hemorrhage.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Don Ilodigwe Research Topics

Disease

8	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 07/2013 - 01/2009
6	Infarction (Infarctions) 07/2013 - 10/2010
4	Ischemia 07/2013 - 10/2010
3	Aneurysm (Aneurysms) 06/2013 - 01/2013
2	Atrophy 07/2013 - 01/2013
2	Cerebral Infarction 07/2011 - 01/2009
1	Encephalomalacia 07/2013
1	Systemic Inflammatory Response Syndrome (Sepsis Syndrome) 07/2013
1	Hypothermia 06/2013
1	Brain Ischemia (Cerebral Ischemia) 06/2011
1	Ischemic Stroke 01/2009

Drug/Important Bio-Agent (IBA)

6	clazosentanIBA 07/2013 - 10/2010
3	tirilazadIBA 06/2013 - 01/2009
2	Pharmaceutical PreparationsIBA 07/2011 - 06/2011
1	MagnesiumIBA 06/2013
1	Nicardipine (Dagan)FDA LinkGeneric 06/2013
1	Nimodipine (Modus)FDA LinkGeneric 03/2013
1	Neuroprotective AgentsIBA 01/2009

Therapy/Procedure

2	Surgical Instruments (Clip) 07/2013 - 01/2013
2	Critical Care (Surgical Intensive Care) 07/2013 - 03/2013
1	Catheters 04/2011